Premium
High‐dose neuroleptics for acute brain failure after intensive chemotherapy for acute leukemia
Author(s) -
Andersson B. S.,
Adams F.,
McCredie K. B.
Publication year - 1984
Publication title -
acta psychiatrica scandinavica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.849
H-Index - 146
eISSN - 1600-0447
pISSN - 0001-690X
DOI - 10.1111/j.1600-0447.1984.tb01198.x
Subject(s) - lorazepam , medicine , chemotherapy , acute leukemia , haloperidol , regimen , intensive care , leukemia , cytarabine , anesthesia , intensive care medicine , dopamine
– A 20‐year‐old Caucasian male with acute leukemia developed acute organic brain failure after treatment with intensive cytostatic chemotherapy. His delirious state was successfully controlled by neuroleptic therapy with intravenous haloperidol and lorazepam. We propose that this regimen may be useful in treating organic brain failure following intensive chemotherapy for malignant disease.